[1]
da Silva , L.R.S., da Silva , L.R.S., Costa , Y.K. dos S., da Rocha , F.H.B.P., de Sousa, V.F.A., Pereira, L.M., Fais, J.P., Araújo, J.V.B., de Andrade, S.N.B. and Siriano, T.P. 2024. Analysis of the benefits of developing vaccines against leishmaniasis compared to the classic treatment. Seven Editora. (Aug. 2024), 640–655.